Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

被引:433
|
作者
Ostrand-Rosenberg, Suzanne [1 ]
Sinha, Pratima [1 ]
Beury, Daniel W. [1 ]
Clements, Virginia K. [1 ]
机构
[1] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA
关键词
Tumor immunity; Immune escape; Tumor microenvironment; Tumor-associated macrophages; MHC CLASS-II; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; BEARING HOST; DOWN-REGULATION; RECEPTOR; KAPPA-B; INFLAMMATION;
D O I
10.1016/j.semcancer.2012.01.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment is a complex milieu of tumor and host cells. Host cells can include tumor-reactive T cells capable of killing tumor cells. However, more frequently the tumor and host components interact to generate a highly immune suppressive environment that frustrates T cell cytotoxicity and promotes tumor progression through a variety of immune and non-immune mechanisms. Myeloid-derived suppressor cells (MDSC) are a major host component contributing to the immune suppressive environment. In addition to their inherent immune suppressive function, MDSC amplify the immune suppressive activity of macrophages and dendritic cells via cross-talk This article will review the cell-cell interactions used by MDSC to inhibit anti-tumor immunity and promote progression, and the role of inflammation in promoting cross-talk between MDSC and other cells in the tumor microenvironment. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 50 条
  • [21] Immature myeloid-derived suppressor cells; A bridge between inflammation and cancer
    Musolino, Caterina
    Allegra, Alessandro
    Pioggia, Govanni
    Gangemi, Sebastiano
    ONCOLOGY REPORTS, 2017, 37 (02) : 671 - 683
  • [22] The cross-talk between B cells and macrophages
    Su, Yahui
    Liu, Siyi
    Long, Chen
    Zhou, Zihua
    Zhou, Yanhong
    Tang, Jingqiong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [23] Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
    Salminen, Antero
    Kauppinen, Anu
    Kaarniranta, Kai
    BIOGERONTOLOGY, 2018, 19 (05) : 325 - 339
  • [24] Role of myeloid-derived suppressor cells in tumor immunotherapy
    Martin, Francois
    Apetoh, Lionel
    Ghiringhelli, Francois
    IMMUNOTHERAPY, 2012, 4 (01) : 43 - 57
  • [25] Induction of myeloid-derived suppressor cells by tumor exosomes
    Xiang, Xiaoyu
    Poliakov, Anton
    Liu, Cunren
    Liu, Yuelong
    Deng, Zhong-bin
    Wang, Jianhua
    Cheng, Ziqiang
    Shah, Spandan V.
    Wang, Gui-Jun
    Zhang, Liming
    Grizzle, William E.
    Mobley, Jim
    Zhang, Huang-Ge
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (11) : 2621 - 2633
  • [26] Suppression of T cells by myeloid-derived suppressor cells in cancer
    Chen, Jieying
    Ye, Yingnan
    Liu, Pengpeng
    Yu, Wenwen
    Wei, Feng
    Li, Hui
    Yu, Jinpu
    HUMAN IMMUNOLOGY, 2017, 78 (02) : 113 - 119
  • [27] Nanomedicine Targeting Myeloid-Derived Suppressor Cells Enhances Anti-Tumor Immunity
    Yang, En-Li
    Sun, Zhi-Jun
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (09)
  • [28] Tumor Microenvironment and Myeloid-Derived Suppressor Cells
    Umansky, Viktor
    Sevko, Alexandra
    CANCER MICROENVIRONMENT, 2013, 6 (02) : 169 - 177
  • [29] Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance
    Liu, Qiaofei
    Liao, Quan
    Zhao, Yupei
    MEDICAL HYPOTHESES, 2016, 87 : 34 - 39
  • [30] Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer
    Ohki, Shinji
    Shibata, Masahiko
    Gonda, Kenji
    Machida, Takeshi
    Shimura, Tatsuo
    Nakamura, Izumi
    Ohtake, Toru
    Koyama, Yoshihisa
    Suzuki, Shinichi
    Ohto, Hitoshi
    Takenoshita, Seiichi
    ONCOLOGY REPORTS, 2012, 28 (02) : 453 - 458